<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38623">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02069522</url>
  </required_header>
  <id_info>
    <org_study_id>AL13</org_study_id>
    <nct_id>NCT02069522</nct_id>
  </id_info>
  <brief_title>Healthy Term Infants Fed Milk-Based Formulas</brief_title>
  <official_title>Healthy Term Infants Fed Milk-Based Formulas With A Supplemental Carotenoid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, double blind, crossover study in healthy infants randomized to one of
      two study formulas.  The trial will consist of two 21 day study feeding periods separated by
      a study washout period.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Carotenoid Concentration</measure>
    <time_frame>Change from Baseline to end of Study Period A (~21 Days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Plasma sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carotenoid Concentration</measure>
    <time_frame>Change from Baseline to end Study Periods A (~21 Days) and B (~21 Days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Plasma sample</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Infants</condition>
  <arm_group>
    <arm_group_label>Standard Milk-based Formula Containing Carotenoid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>milk-based ready to feed infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigational Milk-based Formula Containing Carotenoid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>investigational milk-based ready to feed infant formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Milk-based Formula Containing Carotenoid</intervention_name>
    <description>Fed ad libitum</description>
    <arm_group_label>Standard Milk-based Formula Containing Carotenoid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Investigational Milk-based Formula Containing Carotenoid</intervention_name>
    <description>Fed ad libitum</description>
    <arm_group_label>Investigational Milk-based Formula Containing Carotenoid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infant is in good health

          -  Infant is a singleton from a full term birth with a gestational age of 37-42 weeks

          -  Infant's birth weight was &gt; 2490 g (~5 lbs 8 oz)

          -  Infant is between 14 and 28 days of age

          -  Parent(s) confirm intention to feed their infant the study product(s) as the sole
             source of nutrition for the duration of the study

          -  Parent(s) confirm intention not to administer vitamin or mineral supplements, DHA and
             ARA supplements, solid foods/juices to their infant from enrollment through the
             duration of the study

        Exclusion Criteria:

          -  An adverse maternal, fetal or infant medical history that has potential for effects
             on tolerance, growth, and/or development.

          -  Infants using medications (including OTC), home remedies, herbal preparations,
             probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John B Lasekan, PhD, CCRP</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bobbie Swearengin, RN</last_name>
    <phone>614-624-7182</phone>
    <email>bobbie.swearengin@abbott.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tuscon Medical Center</name>
      <address>
        <city>Tuscon</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Hugh S Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northpoint Pediatrics</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Louise Tetrick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Sharon L Groh-Wargo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dayton Clinical Research</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Martin Schear, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 20, 2014</lastchanged_date>
  <firstreceived_date>February 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carotenoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
